Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9688535rdf:typepubmed:Citationlld:pubmed
pubmed-article:9688535lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C0205242lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C0081487lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C0623362lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C0919336lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:9688535lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:9688535pubmed:issue3lld:pubmed
pubmed-article:9688535pubmed:dateCreated1998-8-13lld:pubmed
pubmed-article:9688535pubmed:abstractTextAn aggrecan G1-G2 substrate was used to determine sites within the interglobular domain that were susceptible to cleavage by MT1-MMP. Degradation products were identified by Western blotting with neo-epitope antibodies specific for MMP-derived N- and C-terminal sequences. The results showed that MT1-MMP cleaved at the N341-F342 and D441-L442 bonds, as shown for other MMPs, and also at a site 13 amino acids C-terminal to the N341-F342 site. The G2 product of this additional cleavage was identified by sequence analysis and revealed an N-terminus commencing T355VxxPDVELPLP. The data are consistent with MT1-MMP cleavage at three sites in the aggrecan interglobular domain; one at N342-F342, a second at D441-L442 and a third at Q354-T355.lld:pubmed
pubmed-article:9688535pubmed:languageenglld:pubmed
pubmed-article:9688535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:citationSubsetIMlld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9688535pubmed:statusMEDLINElld:pubmed
pubmed-article:9688535pubmed:monthJullld:pubmed
pubmed-article:9688535pubmed:issn0014-5793lld:pubmed
pubmed-article:9688535pubmed:authorpubmed-author:OkadaYYlld:pubmed
pubmed-article:9688535pubmed:authorpubmed-author:FujiiYYlld:pubmed
pubmed-article:9688535pubmed:authorpubmed-author:SeikeIIlld:pubmed
pubmed-article:9688535pubmed:authorpubmed-author:GüssHHlld:pubmed
pubmed-article:9688535pubmed:authorpubmed-author:FosangA JAJlld:pubmed
pubmed-article:9688535pubmed:issnTypePrintlld:pubmed
pubmed-article:9688535pubmed:day3lld:pubmed
pubmed-article:9688535pubmed:volume430lld:pubmed
pubmed-article:9688535pubmed:ownerNLMlld:pubmed
pubmed-article:9688535pubmed:authorsCompleteYlld:pubmed
pubmed-article:9688535pubmed:pagination186-90lld:pubmed
pubmed-article:9688535pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:meshHeadingpubmed-meshheading:9688535-...lld:pubmed
pubmed-article:9688535pubmed:year1998lld:pubmed
pubmed-article:9688535pubmed:articleTitleMembrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain.lld:pubmed
pubmed-article:9688535pubmed:affiliationOrthopaedic Molecular Biology Research Unit, Melbourne University, Royal Children's Hospital, Parkville, Australia. fosang@cryptic.rch.unimelb.edu.aulld:pubmed
pubmed-article:9688535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9688535pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4312entrezgene:pubmedpubmed-article:9688535lld:entrezgene
entrez-gene:176entrezgene:pubmedpubmed-article:9688535lld:entrezgene
entrez-gene:4317entrezgene:pubmedpubmed-article:9688535lld:entrezgene
entrez-gene:4323entrezgene:pubmedpubmed-article:9688535lld:entrezgene
entrez-gene:4327entrezgene:pubmedpubmed-article:9688535lld:entrezgene
entrez-gene:11096entrezgene:pubmedpubmed-article:9688535lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9688535lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9688535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9688535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9688535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9688535lld:pubmed